These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 29354553)

  • 1. Clinical relevancy and determinants of potential drug-drug interactions in chronic kidney disease patients: results from a retrospective analysis.
    Saleem A; Masood I; Khan TM
    Integr Pharm Res Pract; 2017; 6():71-77. PubMed ID: 29354553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study.
    Khanna J; Kumar S; Mehta S; Chaudhary J; Jain A
    J Pharm Technol; 2024 Jun; 40(3):142-151. PubMed ID: 38784027
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients.
    Murtaza G; Khan MY; Azhar S; Khan SA; Khan TM
    Saudi Pharm J; 2016 Mar; 24(2):220-5. PubMed ID: 27013915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Assessment of Different Decision Support Software from the Perspective of Potential Drug-Drug Interactions in Patients with Chronic Kidney Diseases.
    Bektay MY; Buker Cakir A; Gursu M; Kazancioglu R; Izzettin FV
    Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of potential drug-drug interactions in the cardiac intensive care units. A comparative analysis between 2 tertiary care hospitals.
    Shakeel F; Khan JA; Aamir M; Hannan PA; Zehra S; Ullah I
    Saudi Med J; 2018 Dec; 39(12):1207-1212. PubMed ID: 30520502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Drug Interactions in Hospitalized Urological Patients: A Retrospective Cohort Study.
    Milovanovic IR; Pejcic AV
    Pharmacology; 2024 Jul; ():1-11. PubMed ID: 39079516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there any potential drug-drug interactions with oral inhaler medications?: A retrospective study.
    Tezcan S; Yaban N
    Explor Res Clin Soc Pharm; 2024 Sep; 15():100468. PubMed ID: 39022220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of antimicrobial use on potential major drug-drug interactions in the pediatric Intensive Care Unit patients at University Hospital in Türkiye.
    Albayrak A; Akkuzu E; Karahalil B
    Minerva Pediatr (Torino); 2024 Jun; 76(3):388-394. PubMed ID: 33858128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential drug-drug interactions analysis in Polish pediatric pneumonology units, including cystic fibrosis patients.
    Adamiszak A; Drobińska J; Wojsyk-Banaszak I; Grześkowiak E; Bienert A
    J Clin Pharmacol; 2024 Oct; 64(10):1326-1334. PubMed ID: 38831707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of polypharmacy, antimicrobial-related potential drug-drug interactions in patients with hematological malignancies.
    Oktay Z; Güner R; Kayaaslan B; Hasanoğlu İ; Kaya Kalem A; Özet G
    J Oncol Pharm Pract; 2024 Apr; ():10781552241249419. PubMed ID: 38665130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance and Patterns of Potential Drug-Drug Interactions in Cardiovascular Patients: Focus on Low-Dose Aspirin and Angiotensin-Converting Enzyme Inhibitors.
    Anfinogenova ND; Stepanov VA; Chernyavsky AM; Karpov RS; Efimova EV; Novikova OM; Trubacheva IA; Falkovskaya AY; Maksimova AS; Ryumshina NI; Shelkovnikova TA; Ussov WY; Vaizova OE; Popov SV; Repin AN
    J Clin Med; 2024 Jul; 13(15):. PubMed ID: 39124556
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital.
    Patel VK; Acharya LD; Rajakannan T; Surulivelrajan M; Guddattu V; Padmakumar R
    Australas Med J; 2011; 4(1):9-14. PubMed ID: 23393498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence and clinical relevance of drug interactions in pediatrics.
    Qorraj-Bytyqi H; Hoxha R; Krasniqi S; Bahtiri E; Kransiqi V
    J Pharmacol Pharmacother; 2012 Oct; 3(4):304-7. PubMed ID: 23326100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist impact on medication dosing and billable coding accuracy in outpatients with chronic kidney disease.
    Cypes IN; Prohaska ES; Melton BL
    J Am Pharm Assoc (2003); 2021; 61(2):e153-e158. PubMed ID: 33160871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Clinical Pharmacist Service on Drug-Related Problems and Patient Outcomes for Hospitalized Patients with Chronic Kidney Disease: A Randomized Controlled Trial.
    Song YK; Jeong S; Han N; Na H; Jang HY; Sohn M; Kim YS; Joo KW; Oh KH; Kim DK; Lee H; Oh JM; DrugTEAM Study Group
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33924036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Theory-Informed Behavior Change Intervention to Reduce Inappropriate Prescribing of Nephrotoxins and Renally Eliminated Drugs.
    Kane-Gill SL; Barreto EF; Bihorac A; Kellum JA
    Ann Pharmacother; 2021 Dec; 55(12):1474-1485. PubMed ID: 33855858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and management of drug related problems on a nephrology ward from a pharmacist's point of view.
    Dvořáčková E; Rychlíčková J; Pávek P; Hojný M; Vlček J
    Pharmazie; 2019 Oct; 74(10):625-629. PubMed ID: 31685090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pharmacist participation in chronic kidney disease (CKD) network and CKD manual distribution on drug-related kidney injury.
    Yamamoto T; Nakayama I; Kawakatsu Y; Yamamoto T; Ishigami N; Watanuki K; Okabe T; Yokoyama H
    Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):887-896. PubMed ID: 31038268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review.
    Al Raiisi F; Stewart D; Fernandez-Llimos F; Salgado TM; Mohamed MF; Cunningham S
    Int J Clin Pharm; 2019 Jun; 41(3):630-666. PubMed ID: 30963447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drug-drug interactions among patients with chronic kidney disease in a South-Eastern Nigeria tertiary hospital: a retrospective study.
    Adibe MO; Ewelum PC; Amorha KC
    Pan Afr Med J; 2017; 28():199. PubMed ID: 29610637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.